ArticleBioengineering (Basel, Switzerland)2025
Quality Management for Radiation Oncology In-House Software Products.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Software engineers develop better clinical applications than physicists with coding skills.Journal of applied clinical medical physics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
(1) Objective: To develop and implement an in-house software quality management (ISQM) program to ensure the continuous, consistent quality of in-house software products. (2) Methods: The ISQM program consists of two key components: quality assurance (QA) and comprehensive documentation. The QA component involves code review, acceptance testing, commissioning, and routine quality checks. Documentation requirements encompass a product report, user manual, QA procedures and reports, release notes, version control, and logs. For each software product, the QA process must be completed, and all required documentation must be finalized before clinical deployment. (3) Results: The ISQM program was successfully developed and retrospectively implemented for existing software products. Future software products will adhere to the ISQM framework, ensuring compliance before clinical release. (4) Conclusions: This study demonstrates the successful development and implementation of the ISQM program-a standardized framework for managing the quality of in-house software products. The ISQM program ensures continuous and consistent oversight, playing a critical role in guaranteeing safe and high-quality patient care in the field of radiation oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.